GiveBetter x New York City

Kings Against Violence Initiative

Hospital, school and community violence prevention

Research time: ~3 min on GPT-6 Astra Low + ~1 min on GPT-6.1 Sol
  • Research — reviewed programs, finances and impact evidence.
  • Source audit — checked claims, assumptions and calculations.
  • Modeling — estimated costs, QALYs and uncertainty.

Updated: 2026-10-08

Donate

Summary

What do they do? KAVI supports young people affected by violence in Brooklyn hospitals, schools and communities. Its hospital team helps patients and families recover, de-escalate conflict and connect with continuing support. A conditional reinjury model estimates $12.8M per DALY using the whole recipient's expense.

Why we’re interested in this organization:

  • Hospital contact can identify people at elevated risk soon after violent injury.

  • Follow-up and conflict mediation provide a specific pathway to reduced harm.

  • Original 990 and audited reconciliation establish the full recipient cost and government-funding baseline.

Our main reservations:

  • No KAVI-specific controlled reinjury effect or annual engaged-patient count was located.

  • External HVIP studies are mixed and suggest sustained engagement is crucial.

  • An unrestricted gift supports the broader portfolio and may substitute for public or philanthropic funding.

What do you get for your dollar? $12.8M per DALY in New York City. DALY is our one-year comparison unit. QALY-based health gains and income-welfare equivalents retain their original assumptions; they are not measured clinical DALYs. Partial reinjury clinical reference; household resources assessed unknown.

Supported patient-equivalents -> sustained engagement -> fewer future violent injuries -> fatal/nonfatal finite QALYs.

1. What do they do?

Kings Against Violence Initiative Inc., EIN 81-1626947, is a separate nonprofit with school, hospital and community programs in Central Brooklyn. Scope The hospital program works at bedsides and with families, provides conflict de-escalation and trauma recovery, and refers patients to continuing support. It partners with Kings County Hospital and violence-prevention organizations; KAVI does not provide the hospital's emergency surgery. Hospital pathway

2. Monitoring and information sharing

Measure eligible patients, distinct enrolled patients, sustained engagement, completed services and violent reinjury/mortality using multi-hospital follow-up, including people who disengage. A 2025 St Louis observational evaluation found 7.6% one-year reinjury among participants versus 7.4% among matched controls, with wide uncertainty. Original study A 2026 Boston target-trial emulation found no benefit for any engagement but favorable, imprecise results among the small sustained-engagement subgroup; residual selection remains possible. Its combined reinjury/perpetration endpoint cannot be transferred directly into injuries averted. Original study

3. Qualitative assessment

The promising health mechanism is preventing a subsequent violent injury through trusted ongoing contact, mediation and care linkage. Merely counting bedside contacts misses engagement; converting every mediation into a life saved would be wrong. Schools and community healing may add health value, but no separate QALY credit is assigned here. NYC Health lists KAVI, Man Up! and Save Our Streets at Kings County and funds a wider intervention network. That public baseline remains, and overlapping patients/events cannot receive full credit in each charity's report. City network

Health-first household-resource assessment is unknown, not zero or a measured health share.

4. What do you get for your dollar?

The focused household-resource check leaves signed income and consumption assessed unknown. The retained conditional reinjury reference remains about $12.8M per DALY, with 0.34196402550327254 MSA QALYs at $4,360,879 whole-recipient annual recognized expense. All seven original worlds remain unchanged. Health-first is a focused research disposition, not a measured 90% health share, zero-resource finding or complete portfolio valuation.

The official hospital page describes bedside and family support, recovery planning, follow-up and referrals with hospital and community partners. The recipient page identifies school, hospital and community programs. These pages do not establish actual participant compensation, displaced private care payments or access costs. Original inferred patient-equivalents cannot automatically become unique cash households.

Private medical or counseling payments and work time may change with fewer injuries, but insurance, existing services and paid leave determine net incidence. No retail treatment value, gross wages or ordinary survivor earnings is credited. Full participant and caregiver travel, follow-up time, administration and opportunity costs must survive engagement and clinical-null cases. Any retained compensation needs taxes and benefits withdrawn, alternative providers, household baseline, finite delay/duration and separate public/hospital payer incidence. Positive overlap applies only to gains; provider costs must not be duplicated as household losses. Broader household and community resources remain unquantified, not absent.

Full annual recognized cost is $4,360,879. Because a measured KAVI patient count was unavailable, the model explicitly assumes 35% of marginal unrestricted expenditure reaches the hospital pathway and $5,000 in allocated cost per supported patient. This implies 305.3 annual patient-equivalents, or 0.07 per $1,000 of recipient spending, not an observed output. Only 25% sustain engagement; a transferred 7.4% one-year reinjury baseline and judged 25% causal reduction are then reduced for alternative help, partner credit and gift response. The resulting 0.3706 donor-attributable events produce 0.34 local QALYs. Five percent of prevented events are assumed fatal; survival benefit stops after 30 years with 0.85 utility, 1% annual mortality and 3% discount. Nonfatal injury prevention receives 0.15 utility for two years only. Both severity assumptions are unmeasured. No repeated cohort or lifelong crime reduction is added. Because N=C*l/k, changing C alone scales both modeled capacity and cost; inflation is correctly tested by changing k.

Model, assumptions and sensitivity

Whole recipient annual recognized expense; hospital marginal allocation explicit. Noncash recognized resources retained; external hospital resources excluded.

22-county MSA; .95 beneficiary residence judgment for Brooklyn hospital pathway, not a county-measured rate.

N=C*l/k; E=N*s*R*e*r*a*b; D=sum(t=1..L)u*exp(-m*t)/(1+d)^t; A=sum(t=1..T)exp(-m*t)/(1+d)^t; Qall=E*(f*D+(1-f)*v*A)/(1+d)-h; Qlocal=g*Qall; price10=10*C/Qlocal if positive.

C
4360879 USD (observed). Original FY2024 return and audited reconciliation. [990] [schedule]
l
0.35 formula-defined (judgment). 35% marginal hospital allocation; no current segment budget.
k
5000 USD (judgment). $5000 allocated cost per hospital patient is a modeling assumption, not measured unit cost.
s
0.25 formula-defined (judgment). 25% sustained engagement assumed; Boston observed10.2% among any-engagement patients so this may be optimistic. [boston]
R
0.074 formula-defined (judgment). 7.4% from StLouis matched controls transferred to Brooklyn; not observed KAVI risk. [stl]
e
0.25 formula-defined (judgment). 25% causal injury reduction assumed despite null broad-engagement studies. [boston]
r
0.75 formula-defined (judgment). 75% remains after alternative support.
a
0.7 formula-defined (judgment). 70% KAVI share after partner support.
b
0.5 formula-defined (judgment). Half gift changes total capacity, unverified.
g
0.95 formula-defined (judgment). 95% MSA residence, unverified.
f
0.05 formula-defined (judgment). 5% future injuries fatal; judgment, no KAVI severity mix.
u
0.85 formula-defined (judgment). Survivor utility .85.
L
30 years (judgment). 30-year survival cap.
m
0.01 formula-defined (judgment). 1% annual mortality.
v
0.15 formula-defined (judgment). Nonfatal utility loss .15 per year.
T
2 years (judgment). Two nonfatal health years.
d
0.03 formula-defined (judgment). 3% discount and one-year event timing.
h
0 formula-defined (judgment). Other portfolio/displacement net health provisionally zero; adverse tested.

Conditional reinjury prevention: Cost: $4.4M; New York City health QALYs: 0.34; all-population health QALYs: 0.36. {"C":4360879,"l":0.35,"k":5000,"s":0.25,"R":0.074,"e":0.25,"r":0.75,"a":0.7,"b":0.5,"g":0.95,"f":0.05,"u":0.85,"L":30,"m":0.01,"v":0.15,"T":2,"d":0.03,"h":0}

Limited engagement and weak effect: Cost: $4.4M; New York City health QALYs: 0.01; all-population health QALYs: 0.01. {"C":4360879,"l":0.2,"k":8000,"s":0.1,"R":0.074,"e":0.1,"r":0.75,"a":0.7,"b":0.25,"g":0.95,"f":0.05,"u":0.85,"L":30,"m":0.01,"v":0.15,"T":2,"d":0.03,"h":0}

High engagement and strong prevention: Cost: $4.4M; New York City health QALYs: 13.60; all-population health QALYs: 14.32. {"C":4360879,"l":0.5,"k":3000,"s":0.6,"R":0.1,"e":0.5,"r":0.75,"a":0.7,"b":0.75,"g":0.95,"f":0.1,"u":0.85,"L":30,"m":0.01,"v":0.15,"T":2,"d":0.03,"h":0}

No causal injury reduction: Cost: $4.4M; New York City health QALYs: 0.00; all-population health QALYs: 0.00. {"C":4360879,"l":0.35,"k":5000,"s":0.25,"R":0.074,"e":0,"r":0.75,"a":0.7,"b":0.5,"g":0.95,"f":0.05,"u":0.85,"L":30,"m":0.01,"v":0.15,"T":2,"d":0.03,"h":0}

No benefit and displacement harm: Cost: $4.4M; New York City health QALYs: -0.47; all-population health QALYs: -0.50. {"C":4360879,"l":0.35,"k":5000,"s":0.25,"R":0.074,"e":0,"r":0.75,"a":0.7,"b":0.5,"g":0.95,"f":0.05,"u":0.85,"L":30,"m":0.01,"v":0.15,"T":2,"d":0.03,"h":0.5}

Twice cost per supported hospital patient: Cost: $4.4M; New York City health QALYs: 0.17; all-population health QALYs: 0.18. {"C":4360879,"l":0.35,"k":10000,"s":0.25,"R":0.074,"e":0.25,"r":0.75,"a":0.7,"b":0.5,"g":0.95,"f":0.05,"u":0.85,"L":30,"m":0.01,"v":0.15,"T":2,"d":0.03,"h":0}

No fatal-event prevention: Cost: $4.4M; New York City health QALYs: 0.10; all-population health QALYs: 0.10. {"C":4360879,"l":0.35,"k":5000,"s":0.25,"R":0.074,"e":0.25,"r":0.75,"a":0.7,"b":0.5,"g":0.95,"f":0,"u":0.85,"L":30,"m":0.01,"v":0.15,"T":2,"d":0.03,"h":0}

Combined resources unknown; clinical reference retained: Cost: $4.4M; New York City health QALYs: 0.34; all-population health QALYs: 0.36. Original clinical and annual recognized recipient cost retained; household resources unknown, not zero.

Counterfactual: Standard trauma care, publicly funded mediation network and alternative support persist. Only future reinjury reduction credited; no credit for survival from index trauma.

Attribution: l is marginal hospital allocation; s is sustained engagement; r alternative-help discount; a KAVI-specific share after hospital/partner credit; b net gift-funded capacity. Reinjury and perpetration overlap not added.

Very weak conditional mechanism estimate, not measured KAVI efficacy or unrestricted portfolio expected value. Zero and adverse scenarios are substantively plausible. N is inferred from judged allocation and unit cost rather than observed patients. This is a conditional capacity model and does not establish measured whole-organization cost-effectiveness.

Sensitivity

  • Model is linear in allocation, engagement, risk, prevention effect and gift response; no empirical precision implied.
  • Doubling allocated unit cost doubles price; high case jointly changes plausible but unverified parameters.
  • Public treatment and volunteer opportunity costs are missing; other community health could offset or amplify the priced pathway.

Unresolved inputs

  • Actual KAVI annual patients, retention and hospital-program allocated costs.
  • Controlled multi-hospital reinjury and severity outcomes, MSA residence and alternative assistance.
  • Current unrestricted marginal spending plan and funding substitution.
  • Actual funding-responsive unique participant households, private payment and compensation counterfactuals, retained amounts, net baseline, full participant/caregiver access costs, finite timing and payer incidence.

5. Funding and previous grants

FY2024 original Form 990 shows $4,360,879 expense ($3,522,226 program, $647,538 management and $191,115 fundraising) and $4,168,812 revenue. Government grants supply $2,689,257; $108,000 of contributions are noncash and are not added again. Net assets are $1,919,879, including $1,566,596 without donor restrictions. FY2023 expense comparator is $3,389,059. Schedule D reconciles audited expense to the same FY2024 total. Original return Schedule D A deficit does not establish which next position is unfunded. No current costed expansion plan was found; 0.5 net donation response is a judgment. Hospital resources and public benefits induced by referral are outside recipient costs; this is not full social cost-effectiveness.

Annual expenses

Organization-level spending, including programs, administration and fundraising. The research list averages three comparable, consecutive full fiscal years when available.

  • FY 2023: $3.4M; Kings Against Violence Initiative Inc., 12-month period, Calendar-year accrual Form990 prior comparator. Source
  • FY 2024: $4.4M; Kings Against Violence Initiative Inc., 12-month period, Calendar-year accrual Form990/ScheduleD full expense. Source

6. Sources

  1. FY2024 original Form990. KAVI/IRS, hosted by ProPublica. Published: not stated; retrieved: 2026-09-29.
  2. FY2024 ScheduleD audited reconciliation. KAVI/IRS, hosted by ProPublica. Published: not stated; retrieved: 2026-09-29.
  3. Recipient scope and donation route. KAVI. Published: not stated; retrieved: 2026-10-08.
  4. Hospital services. KAVI. Published: not stated; retrieved: 2026-10-08.
  5. HVIP public and partner baseline. NYC Health. Published: not stated; retrieved: 2026-09-29.
  6. Region-wide HVIP pilot cohort evaluation. Annals of Internal Medicine authors. Published: not stated; retrieved: 2026-09-29.
  7. Boston HVIP target-trial emulation. Annals of Internal Medicine authors. Published: not stated; retrieved: 2026-09-29.